AI accelerates enzyme development
The story so far
Claude 4.7 claims to have discovered and designed new enzymes, reducing the enzyme research and development cycle in the synthetic biology industry by about 80% and optimizing metabolic pathways for multiple enzyme collaborations within cells. The application of AI technology in enzyme design and metabolic pathway optimization aims to improve product yield and stability. Although AI cannot replace human decision-making, it has been used to predict risks and identify bottlenecks. The industry had previously experienced a downturn, but it has rebounded this year driven by AI and policy support. However, it still requires expertise in strain development, metabolic pathway design, key enzyme research and development, and large-scale production. AI can identify candidate enzymes faster by learning vast protein sequences, shortening the screening time.
AI-written from the reports · Updated 20 days ago
Coverage timeline
Follow the coverage to see every side of the story.
- 36Kr · AIClaude 4.7 claims to discover and design new enzymes, helping the synthetic biology field regain capital favor with AI
Claude 4.7 claims to discover and design new enzymes, helping the synthetic biology field regain capital favor with AI. AI reduces the enzyme development cycle by about 80% and is used to optimize metabolic pathways involving multiple enzyme collaborations within cells. AI cannot yet replace human decision-making but is already used to predict risks and identify bottlenecks.